These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 10745941

  • 1. [Bone hyperresorption in neoplastic diseases. Foreword].
    Vinceneux P.
    Presse Med; 2000 Mar 11; 29(9):485-6. PubMed ID: 10745941
    [No Abstract] [Full Text] [Related]

  • 2. [Bone hyperresorption in bone metastases].
    Clézardin P.
    Presse Med; 2000 Mar 11; 29(9):487-91. PubMed ID: 10745942
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of osteolytic bone destruction.
    Mundy GR.
    Bone; 1991 Mar 11; 12 Suppl 1():S1-6. PubMed ID: 1954046
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment.
    Parfitt AM.
    Can J Oncol; 1995 Dec 11; 5 Suppl 1():1-10. PubMed ID: 8853518
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma.
    Bataille R, Chappard D, Klein B.
    Int J Clin Lab Res; 1992 Dec 11; 21(4):283-7. PubMed ID: 1591381
    [Abstract] [Full Text] [Related]

  • 10. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ, Broadus AE.
    Annu Rev Med; 1994 Dec 11; 45():189-200. PubMed ID: 8198376
    [Abstract] [Full Text] [Related]

  • 11. Parathyroid hormone-related protein in hypercalcemia associated with hematological malignancy.
    Firkin F, Schneider H, Grill V.
    Leuk Lymphoma; 1998 May 11; 29(5-6):499-506. PubMed ID: 9643563
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo.
    Chantry AD, Heath D, Mulivor AW, Pearsall S, Baud'huin M, Coulton L, Evans H, Abdul N, Werner ED, Bouxsein ML, Key ML, Seehra J, Arnett TR, Vanderkerken K, Croucher P.
    J Bone Miner Res; 2010 Dec 11; 25(12):2633-46. PubMed ID: 20533325
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.
    Liu H, Liu Z, Du J, He J, Lin P, Amini B, Starbuck MW, Novane N, Shah JJ, Davis RE, Hou J, Gagel RF, Yang J.
    Sci Transl Med; 2016 Aug 24; 8(353):353ra113. PubMed ID: 27559096
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Progress in diagnosis and therapy: Hypercalcemia due to multiple myeloma and wide-spread neoplastic bone metastasis].
    Abe M.
    Nihon Naika Gakkai Zasshi; 2007 Apr 10; 96(4):675-80. PubMed ID: 17506303
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.